Cargando…

The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors

Fractal dimension analysis (FDA) is modern mathematical method widely used to describing of complex and chaotic shapes when classic methods fail. The main aim of this study was evaluating the influence of photodynamic therapy (PDT) with cystein proteases inhibitors (CPI) on the number and morphology...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurczyszyn, Kamil, Osiecka, Beata J., Ziółkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443606/
https://www.ncbi.nlm.nih.gov/pubmed/22991578
http://dx.doi.org/10.1155/2012/793291
_version_ 1782243582973837312
author Jurczyszyn, Kamil
Osiecka, Beata J.
Ziółkowski, Piotr
author_facet Jurczyszyn, Kamil
Osiecka, Beata J.
Ziółkowski, Piotr
author_sort Jurczyszyn, Kamil
collection PubMed
description Fractal dimension analysis (FDA) is modern mathematical method widely used to describing of complex and chaotic shapes when classic methods fail. The main aim of this study was evaluating the influence of photodynamic therapy (PDT) with cystein proteases inhibitors (CPI) on the number and morphology of blood vessels inside tumor and on increase of effectiveness of combined therapy in contrast to PDT and CPI used separately. Animals were divided into four groups: control, treated using only PDT, treated using only CPI and treated using combined therapy, PDT and CPI. Results showed that time of animal survival and depth of necrosis inside tumor were significantly higher in CPI+PDT group in contrast to other groups. The higher value of fractal dimension (FD) was observed in control group, while the lowest value was found in the group which was treated by cystein protease inhibitors. The differences between FD were observed in CPI group and PDT+CPI group in comparison to control group. Our results revealed that fractal dimension analysis is a very useful tool in estimating differences between irregular shapes like blood vessels in PDT treated tumors. Thus, the implementation of FDA algorithms could be useful method in evaluating the efficacy of PDT.
format Online
Article
Text
id pubmed-3443606
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34436062012-09-18 The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors Jurczyszyn, Kamil Osiecka, Beata J. Ziółkowski, Piotr Comput Math Methods Med Research Article Fractal dimension analysis (FDA) is modern mathematical method widely used to describing of complex and chaotic shapes when classic methods fail. The main aim of this study was evaluating the influence of photodynamic therapy (PDT) with cystein proteases inhibitors (CPI) on the number and morphology of blood vessels inside tumor and on increase of effectiveness of combined therapy in contrast to PDT and CPI used separately. Animals were divided into four groups: control, treated using only PDT, treated using only CPI and treated using combined therapy, PDT and CPI. Results showed that time of animal survival and depth of necrosis inside tumor were significantly higher in CPI+PDT group in contrast to other groups. The higher value of fractal dimension (FD) was observed in control group, while the lowest value was found in the group which was treated by cystein protease inhibitors. The differences between FD were observed in CPI group and PDT+CPI group in comparison to control group. Our results revealed that fractal dimension analysis is a very useful tool in estimating differences between irregular shapes like blood vessels in PDT treated tumors. Thus, the implementation of FDA algorithms could be useful method in evaluating the efficacy of PDT. Hindawi Publishing Corporation 2012 2012-09-06 /pmc/articles/PMC3443606/ /pubmed/22991578 http://dx.doi.org/10.1155/2012/793291 Text en Copyright © 2012 Kamil Jurczyszyn et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jurczyszyn, Kamil
Osiecka, Beata J.
Ziółkowski, Piotr
The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors
title The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors
title_full The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors
title_fullStr The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors
title_full_unstemmed The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors
title_short The Use of Fractal Dimension Analysis in Estimation of Blood Vessels Shape in Transplantable Mammary Adenocarcinoma in Wistar Rats after Photodynamic Therapy Combined with Cysteine Protease Inhibitors
title_sort use of fractal dimension analysis in estimation of blood vessels shape in transplantable mammary adenocarcinoma in wistar rats after photodynamic therapy combined with cysteine protease inhibitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443606/
https://www.ncbi.nlm.nih.gov/pubmed/22991578
http://dx.doi.org/10.1155/2012/793291
work_keys_str_mv AT jurczyszynkamil theuseoffractaldimensionanalysisinestimationofbloodvesselsshapeintransplantablemammaryadenocarcinomainwistarratsafterphotodynamictherapycombinedwithcysteineproteaseinhibitors
AT osieckabeataj theuseoffractaldimensionanalysisinestimationofbloodvesselsshapeintransplantablemammaryadenocarcinomainwistarratsafterphotodynamictherapycombinedwithcysteineproteaseinhibitors
AT ziołkowskipiotr theuseoffractaldimensionanalysisinestimationofbloodvesselsshapeintransplantablemammaryadenocarcinomainwistarratsafterphotodynamictherapycombinedwithcysteineproteaseinhibitors
AT jurczyszynkamil useoffractaldimensionanalysisinestimationofbloodvesselsshapeintransplantablemammaryadenocarcinomainwistarratsafterphotodynamictherapycombinedwithcysteineproteaseinhibitors
AT osieckabeataj useoffractaldimensionanalysisinestimationofbloodvesselsshapeintransplantablemammaryadenocarcinomainwistarratsafterphotodynamictherapycombinedwithcysteineproteaseinhibitors
AT ziołkowskipiotr useoffractaldimensionanalysisinestimationofbloodvesselsshapeintransplantablemammaryadenocarcinomainwistarratsafterphotodynamictherapycombinedwithcysteineproteaseinhibitors